Terms: = Sarcomas AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
11 results:
1. Primary Lymphoma of the Heart: A Case Report of Surgical Treatment and Review of the Literature.
Liu S; Ren C; Wang Y
Heart Surg Forum; 2019 May; 22(3):E225-E228. PubMed ID: 31237548
[TBL] [Abstract] [Full Text] [Related]
2. Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.
Potratz J; Tillmanns A; Berning P; Korsching E; Schaefer C; Lechtape B; Schleithoff C; Unland R; Schäfer KL; Müller-Tidow C; Jürgens H; Dirksen U
Mol Oncol; 2016 May; 10(5):677-92. PubMed ID: 26739507
[TBL] [Abstract] [Full Text] [Related]
3. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and flt4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract] [Full Text] [Related]
4. Lymphangiosarcoma of the scalp.
Mamelak AJ; Collie MR; Kroll R; Hanson ML; Harris HM
J Cutan Med Surg; 2014; 18(2):132-6. PubMed ID: 24636440
[TBL] [Abstract] [Full Text] [Related]
5. A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.
Hadj-Hamou NS; Laé M; Almeida A; de la Grange P; Kirova Y; Sastre-Garau X; Malfoy B
Carcinogenesis; 2012 Jul; 33(7):1399-405. PubMed ID: 22532251
[TBL] [Abstract] [Full Text] [Related]
6. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
Kilvaer TK; Valkov A; Sorbye SW; Smeland E; Bremnes RM; Busund LT; Donnem T
J Transl Med; 2011 Jul; 9():104. PubMed ID: 21733164
[TBL] [Abstract] [Full Text] [Related]
7. Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
Kilvaer TK; Valkov A; Sorbye S; Smeland E; Bremnes RM; Busund LT; Donnem T
PLoS One; 2010 Dec; 5(12):e15368. PubMed ID: 21179485
[TBL] [Abstract] [Full Text] [Related]
8. Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile.
Donghi D; Kerl K; Dummer R; Schoenewolf N; Cozzio A
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1230-4. PubMed ID: 20236193
[TBL] [Abstract] [Full Text] [Related]
9. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas.
Näyhä V; Stenbäck F
APMIS; 2008 Feb; 116(2):107-17. PubMed ID: 18321361
[TBL] [Abstract] [Full Text] [Related]
10. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas.
Itakura E; Yamamoto H; Oda Y; Tsuneyoshi M
J Surg Oncol; 2008 Jan; 97(1):74-81. PubMed ID: 18041747
[TBL] [Abstract] [Full Text] [Related]
11. Expression of CD99 in pleomorphic carcinomas of the lung.
Yoo SH; Han J; Kim TJ; Chung DH
J Korean Med Sci; 2005 Feb; 20(1):50-5. PubMed ID: 15716602
[TBL] [Abstract] [Full Text] [Related]
